Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Smith, Adam [D-WA-9]

Rep. Smith, Adam [D-WA-9]

United States · Official source

Records

5,284 records where Rep. Smith, Adam [D-WA-9] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 9944 (119th)referred

TPS Review Act

United States · United States Congress · 23 July 2026

Bill· HRH.R. 9745 (119th)referred

Orlin’s Law

United States · United States Congress · 16 July 2026

Bill· HRH.R. 9432 (119th)referred

LIFT the BAR Act

United States · United States Congress · 24 June 2026

Bill· HJRESH.J.Res. 187 (119th)referred

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model".

United States · United States Congress · 19 May 2026

This joint resolution prohibits the Centers for Medicare & Medicaid Services (CMS) from testing a new Medicare payment model in certain states that involves a prior authorization process and the use of enhanced technology by third-party contractors to determine whether certain claims should be paid. Specifically, the joint resolution nullifies a notice issued by the CMS on July 1, 2025, titled Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model . (On May 12, 2026, the Government Accountability Office issued a letter of opinion stating that this notice constituted an agency rule and is therefore subject to the Congressional Review Act.) The CMS selected six states to participate in this model over a six-year period: New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. Under the model, contracted companies must process prior authorization requests (i.e., requests for coverage determinations before a service is furnished) for certain services using enhanced technology (e.g., artificial intelligence). Contracted companies are paid based on the share of resulting savings. The CMS aims to test the model's ability to produce accurate results while streamlining the prior authorization process for Medicare claims. The model is based in part on similar processes used for Medicare Advantage claims.  CMS began implementing the model on January 1, 2026. This joint resolution prohibits the CMS from continuing to do so.

Bill· HRH.R. 8907 (119th)referred

IMPACT to Save Moms Act

United States · United States Congress · 19 May 2026

Innovative Maternal Payment and Coverage To Save Moms Act or the IMPACT to Save Moms Act This bill requires the Centers for Medicare & Medicaid Services to establish the Perinatal Care Alternative Payment Model Demonstration Project through FY2031 to allow states to test payment models for maternity care, including postpartum care, under Medicaid and the Children's Health Insurance Program (CHIP). 

Bill· HRH.R. 8811 (119th)referred

Moms Matter Act

United States · United States Congress · 14 May 2026

Bill· HRH.R. 8800 (119th)passed

National Defense Authorization Act for Fiscal Year 2027

United States · United States Congress · 13 May 2026

National Defense Authorization Act for Fiscal Year 2027 This bill sets forth policies and authorities for FY2027 for Department of Defense (DOD) programs, activities, and military construction as well as the national security programs of the Department of Energy (DOE). Among other elements, the bill authorizes the procurement of various items, including aircraft and ships; sets active duty and reserve component personnel strength levels; sets policy regarding various aspects of military health care and military compensation; sets policy regarding DOD acquisitions and acquisition management, including contracting authorities and the acquisition workforce; sets policy for various matters related to DOD interactions with foreign nations, including matters concerning Israel, Europe, and the Indo-Pacific; sets policy for various matters related to DOD cybersecurity and artificial intelligence; requires DOD to include projected demand for foreign military sales in certain contexts, including munitions production planning, sustainment planning for major defense acquisition programs, and decisions regarding production rate increases of defense articles; requires DOD to establish an expedited qualification process for new domestic and allied sources of certain strategic materials, including specified metals, alloys, oxides, and magnets; authorizes specified military construction projects and extends the authorization of certain projects from previous fiscal years; and  authorizes the National Nuclear Security Administration, Defense Nuclear Facilities Safety Board, Naval Petroleum Reserves, and Maritime Administration. For additional information on the National Defense Authorization Act (NDAA) see In Focus IF10516, Defense Primer: Navigating the NDAA , and In Focus IF10515, Defense Primer: The NDAA Process .

Resolution· HCONRESH.Con.Res. 86 (119th)open

Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove United States Armed Forces from hostilities with Iran.

United States · United States Congress · 20 April 2026

This concurrent resolution directs the President to remove U.S. Armed Forces from hostilities against Iran unless explicitly authorized by a declaration of war or a congressional authorization for use of military force against Iran. Elements of the U.S. Armed Forces needed to defend the United States, an ally, or a partner from imminent attack are not covered by this requirement provided the President complies with a specified provision of the War Powers Resolution. (The provision generally requires the President to remove U.S. Armed Forces from hostilities no more than 60 days after the President notifies or is required to notify Congress of such involvement, unless Congress authorizes such use. For more information on the War Powers Resolution, see  CRS In Focus 13134 .)

Bill· HRH.R. 8246 (119th)referred

OHH SNAP Act of 2026

United States · United States Congress · 9 April 2026

Bill· HRH.R. 8205 (119th)open

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

United States · United States Congress · 6 April 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.  Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Bill· HRH.R. 8074 (119th)referred

Kira Johnson Act

United States · United States Congress · 25 March 2026